close and back to page

Latest News

Latest News

Abbott Opens New Research and Development Center in China

Abbott is expanding the company's research and development efforts.

No matter where you are in the world, people are looking for ways to maintain and improve their health. In China, Abbott (No. 14 on the DiversityInc Top 50 Companies list) is responding by expanding the company's research and development (R&D) efforts with the grand opening of a newly built, state-of-the-art R&D center in Shanghai. Built with an investment of more than $30 million (USD), the R&D center taps cutting-edge research to develop breakthrough products to help meet the evolving health and lifestyle needs of the local population.


The center, which spans 5,000 square meters (53,820 square feet) and consists of four floors, houses Abbott scientists with expertise related to the company's nutrition and diagnostics divisions under one roof. Prior to this new facility, the two organizations conducted their China R&D operations in a rented space in Shanghai.

Abbott nutrition scientists prepare a new product formulation for sensory testing.

In nutrition, scientists work with local researchers to better understand Chinese consumers' nutritional needs and preferences in order to create innovative science-based products. Researchers develop products for infants, children and aging adults. These products help people get the nutrition they need to live a healthy, active life. Researchers also create specially formulated products that can help people manage and overcome health conditions.

An Abbott diagnostics R&D scientist researches new substances (biomarkers) that may show the presence of disease at the R&D Center in Shanghai.

In diagnostics, the scientists conduct research and develop products for diagnosing and managing major diseases that seriously threaten the health of Chinese people such as infectious diseases, cancers, cardiovascular diseases, as well as endocrine and metabolic diseases. Researchers want to help drive local innovation and accelerate the discovery of new diagnostic tools using a multi-disciplinary, collaborative approach. In addition, Abbott's diagnostics business is building a customer-experience center across the street from the R&D facility to support the company's commitment to driving innovation in the country and also making it easier for local collaborations.

As the health needs of Chinese and global consumers evolve, Abbott continues to expand the company's scientific expertise and global R&D network to provide the latest technology and products so people can achieve optimal health and enjoy their best lives.

Abbott: Top Internship for Healthcare and Tech

Interns have spoken: Abbott is the top college internship program for healthcare and tech & engineering.

Originally Published by Abbott.

Abbott recognizes the need to develop its future leaders early, and has been named the top healthcare and tech & engineering internship program by Vault.

Read More Show Less

New Study Shows Abbott's Novel Diagnostic Test Could Help Rule Out Heart Attacks Earlier

Preliminary research indicates that a diagnostic test currently in development, that is done at the patient's side in minutes, has similar accuracy to a high-sensitive troponin test for early rule out of a heart attack .

Originally Published by Abbott.

For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether someone is having a heart attack. New data, published online in JAMA Cardiology, found a new blood test under development that is done right at the patient's side in as little as 15 minutes could identify nearly three-fifths (56.7 percent) of people at low-risk of experiencing a heart attack, similar to the results of a High Sensitive Troponin-I blood test done in the laboratory setting.

Read More Show Less

Abbott: Partnering for a Healthier Future

Abbott supports the First Ladies of Africa in the fight to end AIDS in children and keep mothers healthy.

Originally Published by Abbott.

In countries around the world, Abbott is working across its businesses and in partnerships with others to create healthier futures for families. One example: since 2014, Abbott's diagnostics business has supported the work of the Organization of African First Ladies Against HIV/AIDS (OAFLA – pictured above) to fight the AIDS epidemic in Africa, particularly among pregnant women and children – who are among the most vulnerable populations impacted by the disease.

At an OAFLA meeting on the sidelines of the UN General Assembly in New York City, Abbott and several other organizations are being recognized by OAFLA for longstanding partnership and support, including public-private partnerships that bring together technical, financial and other resources to focus on a global health challenge such as HIV/AIDS.

Read More Show Less

Abbott: DRG Stimulator, A Life Changing Technology for Chronic Pain.

The new technological DRG therapy may be the key to easing daily tasks for those with chronic pain.

Originally Published by Abbott.

Living with chronic pain affects not just your body but also your mind. It can make getting around and getting along equally difficult.

But with innovation in health technology comes hope. Abbott has developed a new device found to be more effective than traditional therapy at relieving chronic pain.

Read More Show Less

Abbott: Expediting Blood Testing With i-Stat

The portable, handheld i-STAT Alinity delivers quick blood test results anywhere you are.

Originally Published by Abbott.

Every day, countless blood samples are tested all around the world for one purpose: to help diagnose and treat medical conditions. From the couple eagerly awaiting the results of a pregnancy blood test to a worried cancer patient hoping for more answers, diagnostic blood tests give vital insight into what's happening underneath the skin.

Read More Show Less

Abbott: Freestyle Libre 14 Day, Now FDA Approved

Abbott's flash glucose monitor now FDA-approved for two weeks of use in U.S. between sensor changes.

Originally Published by Abbott.

The U.S. Food and Drug Administration has approved FreeStyle Libre 14 day— Abbott's revolutionary continuous glucose monitoring system. In the U.S., you can wear the sensor up to 14 days with high accuracy.

Read More Show Less

At Abbott, You Look Like An Engineer

Decades before #ILookLikeAnEngineer, Abbott paved the way for a non-profit dedicated to diversity in STEM.

Originally Published by Abbott.

#ILookLikeAnEngineer.

Remember this? A few years ago, a young software engineer was featured in a recruiting advertisement, only to be accused of not being an actual engineer. Frustrated with the assertion, Isis Wenger started a movement to break the stereotype of what an engineer should look like.

Read More Show Less

Abbott Receives FDA Approval for Next-Generation MitraClip Device to Treat People with Leaky Heart Valves

MitraClip is the gold-standard minimally invasive alternative to open-heart surgery for people needing mitral valve repair.

Originally Published by Abbott.

Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for a next-generation version of its leading MitraClip® heart valve repair device used to repair a leaky mitral valve without open-heart surgery. The transcatheter clip-based therapy, now on a third generation of product innovations, has been used to treat more than 65,000 patients worldwide over the last ten years.

Read More Show Less